Sign Out
Pregnancy: The safety of Cinnarizine & Dimenhydrinate combination in human pregnancy has not been established. Animal studies are insufficient with respect to effects on pregnancy, embryonal/foetal development and postnatal development.
The teratogenic risk of the single actives dimenhydrinate/diphenhydramine and cinnarizine is low. No teratogenic effects were observed in animal studies. There are no data from the use of Cinnarizine & Dimenhydrinate combination in pregnant women. Animal studies are insufficient with respect to reproductive toxicity. Based on human experience dimenhydrinate is suspected to have an oxytoxic effect and may shorten labour. Cinnarizine & Dimenhydrinate combination is not recommended during pregnancy.
Breast-feeding: Dimenhydrinate and cinnarizine are excreted in human breast milk. Cinnarizine & Dimenhydrinate combination should not be used during breast-feeding.
Continue with Google